Tarja Stenvall Appointed Chief Executive Officer of Bavarian Nordic

Bavarian Nordic A/S announced the appointment of Tarja Stenvall as President and Chief Executive Officer, effective October 15, 2026, replacing Paul Chaplin. Stenvall brings over 20 years of global healthcare leadership experience from Sanofi, AstraZeneca, and Pfizer, with expertise in scaling vaccine and pharmaceutical businesses. The company positions itself as a leading global vaccine supplier with a strong foundation for future growth.